CRISPR Therapeutics AG (CRSP) Social Stream
CRISPR THERAPEUTICS AG (CRSP) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CRISPR THERAPEUTICS AG.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 16 | $220 | $100 | $160.266 | $64.84 | 147.17% |
| 2022-02-02 | 16 | $220 | $100 | $160.692 | $64.84 | 147.83% |
| 2022-02-04 | 17 | $220 | $100 | $158.846 | $64.84 | 144.98% |
| 2022-02-16 | 17 | $220 | $64 | $154.714 | $64.84 | 138.61% |
| 2022-02-17 | 17 | $220 | $64 | $154.785 | $64.84 | 138.72% |
| 2022-02-25 | 17 | $220 | $64 | $153 | $64.84 | 135.97% |
| 2022-05-09 | 16 | $220 | $64 | $152.461 | $64.84 | 135.13% |
| 2022-05-10 | 16 | $220 | $52 | $150.692 | $64.84 | 132.41% |
| 2022-05-12 | 16 | $220 | $52 | $140.714 | $64.84 | 117.02% |
| 2022-05-13 | 16 | $220 | $52 | $139.466 | $64.84 | 115.09% |
| 2022-05-16 | 16 | $220 | $52 | $137.8 | $64.84 | 112.52% |
| 2022-05-17 | 16 | $220 | $52 | $132.533 | $64.84 | 104.4% |
| 2022-05-23 | 16 | $220 | $52 | $128.2 | $64.84 | 97.72% |
| 2022-06-12 | 17 | $220 | $46 | $123.062 | $64.84 | 89.79% |
| 2022-06-13 | 17 | $220 | $46 | $123.375 | $64.84 | 90.28% |
| 2022-06-16 | 17 | $220 | $46 | $123.375 | $64.84 | 90.28% |
| 2022-06-22 | 17 | $220 | $46 | $121.882 | $64.84 | 87.97% |
| 2022-07-11 | 18 | $220 | $46 | $116.888 | $64.84 | 80.27% |
| 2022-08-02 | 17 | $220 | $46 | $118.555 | $64.84 | 82.84% |
| 2022-08-09 | 20 | $220 | $46 | $117.555 | $64.84 | 81.3% |
| 2022-08-10 | 20 | $220 | $46 | $117.411 | $64.84 | 81.08% |
| 2022-08-15 | 20 | $220 | $46 | $114.187 | $64.84 | 76.11% |
| 2022-09-28 | 19 | $220 | $46 | $114.312 | $64.84 | 76.3% |
| 2022-10-11 | 20 | $220 | $37 | $109.764 | $64.84 | 69.28% |
| 2022-11-02 | 20 | $220 | $37 | $104.055 | $64.84 | 60.48% |
| 2022-11-06 | 20 | $220 | $37 | $103.944 | $64.84 | 60.31% |
| 2022-11-07 | 20 | $220 | $37 | $104 | $64.84 | 60.39% |
| 2023-01-04 | 20 | $220 | $37 | $102.888 | $64.84 | 58.68% |
| 2023-01-12 | 21 | $220 | $37 | $101.421 | $64.84 | 56.42% |
| 2023-01-23 | 20 | $220 | $37 | $98.888 | $64.84 | 52.51% |
| 2023-02-08 | 21 | $220 | $37 | $97.368 | $64.84 | 50.17% |
| 2023-02-22 | 22 | $220 | $37 | $97.368 | $64.84 | 50.17% |
| 2023-02-23 | 22 | $220 | $37 | $93.108 | $64.84 | 43.6% |
| 2023-02-27 | 22 | $220 | $39 | $93.213 | $64.84 | 43.76% |
| 2023-03-03 | 22 | $220 | $39 | $92.897 | $64.84 | 43.27% |
| 2023-03-07 | 23 | $220 | $39 | $90.553 | $64.84 | 39.66% |
| 2023-03-27 | 23 | $220 | $39 | $90.153 | $64.84 | 39.04% |
| 2023-04-03 | 23 | $220 | $39 | $87.24 | $64.84 | 34.55% |
| 2023-05-08 | 24 | $220 | $39 | $86.548 | $64.84 | 33.48% |
| 2023-05-09 | 24 | $220 | $39 | $86.366 | $64.84 | 33.2% |
| 2023-05-12 | 24 | $220 | $42 | $85.59 | $64.84 | 32% |
| 2023-05-23 | 23 | $220 | $42 | $88.19 | $64.84 | 36.01% |
| 2023-06-09 | 24 | $220 | $42 | $87.954 | $64.84 | 35.65% |
| 2023-06-14 | 24 | $220 | $42 | $88.409 | $64.84 | 36.35% |
| 2023-08-08 | 22 | $220 | $42 | $91.3 | $64.84 | 40.81% |
| 2023-08-11 | 22 | $220 | $42 | $90.65 | $64.84 | 39.81% |
| 2023-08-16 | 23 | $220 | $43 | $90.7 | $64.84 | 39.88% |
| 2023-09-27 | 22 | $220 | $43 | $91.2 | $64.84 | 40.65% |
| 2023-11-06 | 23 | $220 | $43 | $91.2 | $64.84 | 40.65% |
| 2023-11-07 | 23 | $220 | $43 | $91.4 | $64.84 | 40.96% |
| 2023-11-10 | 23 | $220 | $43 | $90.85 | $64.84 | 40.11% |
| 2023-11-16 | 24 | $220 | $42 | $90.8 | $64.84 | 40.04% |
| 2023-12-06 | 25 | $220 | $42 | $89.181 | $64.84 | 37.54% |
| 2023-12-11 | 25 | $188 | $30 | $84.913 | $64.84 | 30.96% |
| 2023-12-13 | 24 | $188 | $30 | $86.5 | $64.84 | 33.41% |
The Trend in the Analyst Price Target
CRSP's average price target has moved up $0.91 over the prior 31 weeks.
CRSP reports an average of 69.03% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-27 | 23 | 220 | 39 | 87.240 | 44.35 | 96.71% |
| 2023-05-23 | 24 | 220 | 42 | 88.190 | 67.20 | 31.24% |
| 2023-06-09 | 24 | 220 | 42 | 87.954 | 61.24 | 43.62% |
| 2023-06-14 | 24 | 220 | 42 | 88.409 | 58.96 | 49.95% |
| 2023-06-14 | 22 | 220 | 42 | 87.952 | 58.96 | 49.17% |
CRSP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.03 | 14 | 1 | 7 | 2 | 2 | 25 |
The Trend in the Broker Recommendations
Over the past 46 months, CRSP's average broker recommendation rating worsened by 0.37.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CRISPR THERAPEUTICS AG's variance in analysts' estimates is lower than -7735.51% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, CRISPR THERAPEUTICS AG's number of analysts covering the stock is greater than 7499.95% of them.
- CRISPR THERAPEUTICS AG's average analyst price target is higher than 7047.36% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the large market cap category, CRISPR THERAPEUTICS AG's upside potential (average analyst target price relative to current price) is greater than 6675.08% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CRISPR THERAPEUTICS AG are QGEN, BLUE, and NVAX.
View All Top Stocks by Price Target
Is CRSP a Buy, Hold or Sell? See the POWR Ratings now!